Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00333749
Other study ID # 3870505
Secondary ID
Status Completed
Phase Phase 1
First received January 13, 2006
Last updated September 3, 2009
Start date January 2006
Est. completion date December 2007

Study information

Verified date September 2009
Source HaEmek Medical Center, Israel
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

Children with acute diseases with oral ulcers (not included PRESENTATIONS OF SLE, IBD or IMMUNOCOMPRMIZED STATES)will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk. Children will than be followed for length of the disease - signs and symptoms.


Description:

A prospective randomized controlled study that will include 110 previously health 6months - 5 years children (55 in each group) with acute oral ulcer disease (< 48 hours). Children will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk. Children will than be followed for length of the disease - sings and symptoms by questioner to parents, and physical examination by there physicians. .


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date December 2007
Est. primary completion date December 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 6 Months to 5 Years
Eligibility Inclusion Criteria:

- Age > 6 months or < 5 years.

- Acute (< 48 hours) oral ulcer disease.

- > 5 ulcers.

- Cooperative parents .

- Signing inform consent.

Exclusion Criteria:

- All types of immunosuppression, IBD, SLE, recurrent oral ulcer, disease > 48 hours, age , 6 < months or > 5 years.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
Drinking or rinsing the mouth 2-3 times for 1 day

Pasturlized cow milk
Drinking or rinsing the mouth 2-3 times for one day.

Locations

Country Name City State
Israel Dan Miron Afula

Sponsors (1)

Lead Sponsor Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Severity of disease 3 years
Primary Length of disease 3 years
See also
  Status Clinical Trial Phase
Completed NCT03239834 - Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Not yet recruiting NCT04989049 - Therapeutic Effect of Folic Acid in Healing of Oral Ulcers Early Phase 1
Completed NCT06379438 - Treatment of Aphtous Ulcers With Photodynamic Therapy N/A
Withdrawn NCT02769494 - The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer Phase 3
Completed NCT05413096 - Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis Early Phase 1
Completed NCT03633292 - Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers Phase 4
Recruiting NCT04710888 - Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis Phase 2
Completed NCT05147376 - Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances Early Phase 1
Completed NCT04383236 - Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis N/A
Completed NCT03167632 - Oral Ulcer Prevalence: Hospital-based Cross-sectional Study N/A
Enrolling by invitation NCT05288478 - Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. Phase 2
Recruiting NCT05449548 - Lenalidomide in the Treatment of Mucosal Behçet's Syndrome N/A
Completed NCT05032248 - Uses of Tacrolimus in Behcet Disease N/A